ZERGA, M. New therapeutic options for relapsed/refractory diffuse large b-cell lymphoma. Treatment with tafasitamab + lenalidomide. Journal of Hematology, [S. l.], v. 29, n. 3, p. 61–70, 2026. DOI: 10.48057/hematologa.v29i3.687. Disponível em: https://mail.revistahematologia.com.ar/index.php/Revista/article/view/687. Acesso em: 18 nov. 2026.